Record Revenue, But Earnings Lean on Inventory Crutch
KRBL delivered record quarterly revenue of ₹1,727 Cr and PAT growth of +50.4%, but a critical discrepancy on the call—stated PAT of ₹159 Cr vs. delivered ₹259 Cr—raises earnings credibility concerns. More fundamentally, the profit surge rests on depleting low-cost paddy inventory, not organic business improvement.
₹259 Cr
+50.4% YoY
₹159 Cr
–62% discrepancy
14.6% NPM
EBITDA 21.1% (vs 16.6% prior year)
1.5 quarters
Then cost pressure begins
KRBL reported its highest-ever quarterly revenue at ₹1,727 Cr (+14.3% YoY) and a stunning 50.4% YoY jump in PAT to ₹259 Cr. On the surface, a blowout. But the headline obscures two material problems: a credibility gap on the call itself, and a profit surge built on temporary inventory advantage rather than business improvement.
The PAT discrepancy: credibility red flag
On the earnings call, CFO Ashish Jain stated Q2 consolidated PAT at ₹159 Cr with a 14.6% margin. The verified result filed with BSE shows ₹259 Cr—a ₹99 Cr gap or 62% understatement. The math checks: revenue of ₹1,727 Cr × 14.6% margin = ₹252 Cr, perfectly consistent with the delivered ₹259 Cr. The call's ₹159 Cr figure is unexplained and material. Management offered no clarification on the discrepancy.
PAT for the quarter was at INR159 crores or 14.6% in margin terms as against INR172 crores or 11.2% in the corresponding quarter.
Where the profit actually came from
Set the PAT misstatement aside; even the verified ₹259 Cr profit deserves scrutiny. KRBL's margin expansion—from 16.6% EBITDA last year to 21.1% this quarter—is real. But the driver is not organic business improvement. It is low-cost paddy inventory.
KRBL holds ₹2,203 Cr of paddy inventory at old-crop costs (purchased before prices spiked). This old inventory is being milled and sold at current market realization, pocketing the spread. But the runway is short: at current utilization, the company has 1.5 quarters of old-crop paddy left before it must source at new, inflated prices.
Domestic surge is real; export collapse is not
The one bright spot with sustainable legs is domestic growth. Q2 domestic revenue grew 33% YoY, driven by branded rice (+23% YoY, with consumer packs +31%) and regional rice (+42% YoY, nearly double the 25% guidance). India Gate brand continues to strengthen: market share stands at 36% in general trade and 39.6% in modern trade, up from ~33% prior year. Masala division is tracking toward the ₹25 Cr annualized target (H1 sales ₹4.5 Cr vs ₹3.1 Cr prior year).
But this domestic engine cannot fully mask the export wreck. Q2 exports fell 31% YoY to ~₹297 Cr, with bulk basmati volumes down to 2.5MT vs. 2.7MT prior year. The Middle East—which represents 75% of KRBL's export mix—remains in crisis. Payment channels are stressed (Iran sanctions), freight costs inflated, and the Strait of Hormuz transit risk has deterred shipments. Management's export recovery is contingent on Iran-US geopolitical normalization, with potential upside of 10,000–40,000 MT if settled. Until then, bulk business is effectively paused.
Record quarterly revenue ₹1,727 Cr, +14% YoY
Domestic growth 33% YoY
Regional rice +42% YoY (beats 25% guidance by 68%)
PAT 159 Cr stated on call
10% FY27 domestic volume growth (reaffirmed)
Export recovery contingent on Iran-US deal; no base-case scenario offered
What changed on this call
EBITDA margin guidance raised: Prior FY27 guidance was 17–18%; management now guides 17–19%. Q2 delivered 21.1%, suggesting confidence in the upper band. But the raise is more of a recalibration than an upgrade—Q2's 21.1% is likely unsustainable into H2 as new-crop paddy costs flow through. A 17–19% range is still below the Q2 run-rate and below the prior-year unsustainable 23.8%.
Domestic growth trajectory intact; exports reset downward: The 10% FY27 domestic volume growth guidance stands (on track for delivery given H1 32% growth). But export recovery is now explicitly tied to geopolitical outcomes, with management offering no volume or revenue guidance for a base-case scenario. This is a strategic de-risking; it also signals management does not expect near-term recovery.
Paddy cost risk acknowledged but not fully quantified: Ayush Gupta (Head-India Business) acknowledged paddy price inflation openly but deferred on precise margin impact. He guided Q3 EBITDA to 16–20%, a wide band that effectively says 'uncertain.' This is more honest than false precision, but it limits investor confidence in the margin trajectory.
How the street is positioned
KRBL stock closed at ₹405.1 as of November 9, 2026, trading well above its 20-day, 50-day, and 200-day simple moving averages (₹379, ₹394, ₹364 respectively). The stock is +47.5% off its 52-week low of ₹274.65 and –39.99% from its all-time high of ₹675, a substantial discount that reflects both sector headwinds and the market's caution on near-term earnings sustainability.
FII ownership has edged down: Foreign institutional investors held 7.28% in Q1 FY27 (down 0.48 percentage points from 7.76% in Q4 FY26), a modest but deliberate trim. This suggests foreign money is taking profits on the post-result rally or waiting for clarity on margin sustainability. Domestic institutional ownership is negligible at 0.70%, and promoter stake remains locked at 60.17%.
RSI at 60.2 sits in neutral territory—neither overbought nor oversold—consistent with a stock that has run from lows but not reached euphoric levels. Volume is normal. No bulk or block trades are flagged, suggesting no insider or promoter activity around the result.
Ranked risks for a holder
Paddy cost inflation eroding low-cost inventory advantage
High1.5 quarters of margin cushion remain. New-crop paddy prices +30% (INR 4,500/qtn). Once inventory depletes, Q3–Q4 will face upward cost pressure. 16–20% EBITDA in Q3 vs. 21.1% Q2 represents ~5 percentage point margin compression year-over-year unless pricing offsets.
PAT stated on call vs. delivered result—credibility gap
High₹99 Cr (62%) discrepancy between call figure and BSE filing unexplained. Raises questions about management disclosure discipline. If this reflects a misstatement rather than a one-time accounting item, investor trust is damaged.
Export business dependency on geopolitical normalization
HighBulk exports (41% of H1 revenue) are down 31% YoY and nearly paused due to Middle East payment stress, Hormuz transit risk, freight inflation. Recovery is explicitly contingent on Iran-US deal. No base-case guidance offered. If geopolitical resolution takes >12 months, KRBL forgoes ₹100+ Cr of revenue and must absorb costs.
Inventory accounting opacity
MediumPaddy inventory at ₹2,203 Cr is a material asset. Rapid depletion combined with sharp price move creates risk of margin cliff. Detailed visibility into blending strategy (old-crop vs. new-crop mix per unit) not disclosed; limits ability to model quarter by quarter.
Domestic growth moderation if consumer price elasticity bites
MediumDomestic growth of +33% YoY is strong but partly supported by pricing. If paddy costs force KRBL to raise consumer pack prices beyond +15–18% already taken, volume elasticity may kick in. Regional rice (the growth star at +42%) is price-sensitive.
The debate
The honest read: KRBL delivered a strong domestic quarter with real business momentum (regional rice +42% YoY, India Gate scaling). But the headline profit number is misleading. The +50.4% YoY PAT jump is not organic; it is a temporary spread on low-cost inventory that will vanish in H2. Export collapse (-31% YoY, >75% Middle East dependent) is a material drag and recovery is geopolitically uncertain. FY27 guidance is achievable on the volume side (10% domestic) but margin sustainability is the crux. The call's PAT discrepancy (159 vs. 259 Cr) is a red flag that erodes confidence in disclosure.
The verdict
Hold
Confidence 6/10
Strong
+33% YoY; India Gate scaling real
Weak
Inventory cushion exhausts in 1.5 qtrs
Q3 EBITDA margin
Test if guidance 17–19% holds or compresses below
1 · Q3 EBITDA margin trajectory
Management guided 16–20% for Q3 (wide band). The real test is whether realized margin tracks upper band (18–20%) or sinks toward lower band (16–17%). This will determine whether the high-margin inventory advantage is truly spent or merely compressing. If Q3 delivers <17%, expect material multiple compression.
2 · Iran-US geopolitical normalization and export timing
Management pegged export recovery to this outcome explicitly. Monitor news on US-Iran nuclear negotiations. If settlement occurs by Dec 2026 / Jan 2027, KRBL could see 10,000–40,000 MT recovery in bulk shipments by Q4 FY27, partially offsetting H2 margin pressure. If negotiations stall, export headwind persists into FY28.
3 · Paddy inventory mix shift and domestic pricing sustainability
As old-crop inventory depletes, monitor the pace of new-crop procurement and blended cost per unit. If KRBL is forced to raise domestic consumer pack prices by >18% to offset cost inflation, watch for volume elasticity in the Q3–Q4 print. Regional rice at +42% growth is most vulnerable to pricing.
4 · Management clarity on the PAT discrepancy
The 62% gap between call stated (₹159 Cr) and delivered (₹259 Cr) remains unexplained. At the Q3 earnings call, expect analysts to press hard on this. If management does not offer a clear explanation, credibility damage will widen. If they do explain (e.g., standalone vs. consolidated difference, a typo), it needs to be airtight.
KRBL delivered a headline-beating quarter on the back of strong domestic growth and profitable old-crop inventory drawdown. The market has correctly noted both: FII has trimmed slightly post-result, RSI sits neutral, and the stock holds the 52-week run-up from lows (+47.5%) without reaching excess. But the step-change in earnings is not here. This is a one-quarter inventory benefit overlaid on genuine domestic business progress. The single number to track from here is Q3 EBITDA margin. If it holds at or above 18%, management's guidance holds and the multiple may re-rate. If it sinks below 17%, the temporary nature of the Q2 surge becomes undeniable, and the stock will likely test lower. Domestic momentum is the only sustainable engine; on that alone, the company merits a hold, not a buy. The export recovery is a free option, not a base case.
Informational and educational content only. Not investment advice.